CD9 Tetraspanin Interacts with CD36 on the Surface of Macrophages: A Possible Regulatory Influence on Uptake of Oxidized Low Density Lipoprotein by Huang, Wenxin et al.
CD9 Tetraspanin Interacts with CD36 on the Surface of
Macrophages: A Possible Regulatory Influence on Uptake
of Oxidized Low Density Lipoprotein
Wenxin Huang
1, Maria Febbraio
2,3, Roy L. Silverstein
1,3*
¤
1Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, 2Department of Molecular Cardiology, Lerner
Research Institute, Cleveland, Ohio, United States of America, 3Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case, Western Reserve
University, Cleveland, Ohio, United States of America
Abstract
CD36 is a type 2 scavenger receptor with multiple functions. CD36 binding to oxidized LDL triggers signaling cascades that
are required for macrophage foam cell formation, but the mechanisms by which CD36 signals remain incompletely
understood. Mass spectrometry analysis of anti-CD36 immuno-precipitates from macrophages identified the tetraspanin
CD9 as a CD36 interacting protein. Western blot showed that CD9 was precipitated from mouse macrophages by anti-CD36
monoclonal antibody and CD36 was likewise precipitated by anti-CD9, confirming the mass spectrometry results.
Macrophages from cd36 null mice were used to demonstrate specificity. Membrane associations of the two proteins on
intact cells was analyzed by confocal immunofluorescence microscopy and by a novel cross linking assay that detects
proteins in close proximity (,40 nm). Functional significance was determined by assessing lipid accumulation, foam cell
formation and JNK activation in wt, cd9 null and cd36 null macrophages exposed to oxLDL. OxLDL uptake, lipid
accumulation, foam cell formation, and JNK phosphorylation were partially impaired in cd9 null macrophages. The present
study demonstrates that CD9 associates with CD36 on the macrophage surface and may participate in macrophage
signaling in response to oxidized LDL.
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Introduction
CD36 is a member of the Type 2 scavenger receptor family. It
recognizes multiple endogenous and exogenous ligands, including
proteins containing thrombospondin type 1 structural homology
regions (TSR) [1,2]; oxidized phospholipids expressed on
oxidatively midified low-density lipoprotein (oxLDL), apoptotic
cells, and cell-derived microparticles [3,4,5]; long chain fatty acids
[6]; amyloid-b [7]; falicparum malaria-infected erythrocytes; and
specific components of microbial cell walls [8]. CD36 is expressed
on a variety of cells including platelets [9], monocytes, macro-
phages, dendritic cells, microvascular endothelial cells [10],
adipocytes, myocytes, and certain specialized epithelial cells
[11,12]. As a widely expressed receptor with multiple ligands,
CD36 is involved in a numerous biological and pathological
processes including fatty acid uptake and sensing, innate
immunity, inflammation, atherosclerosis, and angiogenesis [13].
Much of the function of CD36 depends on ligand-induced
triggering of specific intracellular signaling cascades. For example,
TSR containing proteins inhibit angiogenesis by inducing a
CD36-dependent pro-apoptotic signal in microvascular endothe-
lial cells via direct activation of Fyn, p38 MAP kinase and caspase-
3 [14], as well as up-regulation of the Fas and TNFa mediated
apoptotic pathways [15,16]. On macrophages, oxLDL induces
CD36-mediated recruitment and activation of Lyn and activation
of Vav family guanine nucleotide exchange factors and c-Jun N-
terminal kinase (JNK)-2 [17,18,19]. These pro-atherogenic
pathways are required for internalization of oxLDL, foam cell
formation, and inhibition of migration. CD36-mediated activation
of platelets shares features with the macrophage pathway in that
Lyn, JNK2, and Vav are all activated by CD36 in a ligand-
dependent manner, providing a mechanistic link between oxidant
stress, inflammation and thrombosis [20,21,22,23].
The precise mechanisms of CD36-mediated cell signaling are
incompletely understood. It has 2 very short intra-cytoplasmic
domains and no inherent intracellular enzymatic activity, but its
carboxy-terminal cytoplasmic domain has been shown to interact
with intracellular signaling proteins, including src-family kinases
and MAP kinase kinases [17]. Mutations or deletions in the
carboxy terminal domain abolish signaling responses in transfected
cells [24,25]. Several aspects of CD36 function and signaling are
known to require functional and/or physical association with other
membrane receptors, including integrins and toll-like receptors
(TLR) [26,27]. For example, uptake of apoptotic cells by dendritic
cells and uptake of shed photoreceptor outer segments by retinal
pigment epithelial cells involve both CD36 and aVb5 integrin
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wall glycolipids require both CD36 and TLR-2 containing
complexes, and a CD36-TLR4-TLR6 pathway has been impli-
cated in microglial responses to oxLDL and amyloid-b [30]. The
structural mechanisms by which CD36 serves as a membrane co-
receptor are not well understood, but may relate in part to co-
localization in membrane microdomains.
The tetraspanin family of membrane proteins has recently been
implicated in cell signaling via their ability to compartmentalize
other membrane proteins including integrins, along with intracel-
lular signaling molecules, such as small molecular weight GTP
binding proteins, in plasma membrane domains [31,32]. Tetra-
spanins are a widely expressed, highly conserved group of more
than 30 proteins that span the plasma membrane 4 times and that
contain a conserved cysteine motif in their cytoplasmic amino and
carboxy terminal domains [33]. Specific tetraspanins have been
shown to regulate cell adhesion, migration, activation and
proliferation in inflammation, immune responses, hemostasis/
thrombosis, cancer metastasis, and sperm-egg fusion. Previous
studies indicated that the tetraspanin CD9 could be co-
immunoprecipitated with CD36 from human platelets or endo-
thelial cells [34,35], but no functional significance was identified.
We therefore tested the hypothesis that CD9 on macrophages
would interact with CD36 and contribute to CD36-mediated
functional responses. Using a combination of proteomic, immuno-
localization and functional approaches we now report that
macrophage CD9 associates with CD36 on the cell surface and
participates in CD36-dependent uptake of oxLDL.
Results
Co-precipitation of macrophage CD9 and CD36 by
monoclonal antibodies
In preliminary experiments we used mass spectrometry to
identify proteins immunoprecipitated from mouse peritoneal
macrophage lysates by a monoclonal anti-CD36 IgA. The
precipitates were analyzed by SDS-PAGE and then subjected to
LC-MS. Multiple CD36 peptides were detected in the appropriate
MW region in the gels and in the lowest molecular weight region
we identified four specific peptides representing 21% amino acid
coverage of CD9. CD9 peptides were not detected in immuno-
precipitates from cd36 null macrophages, demonstrating specific-
ity. To confirm and validate these results we performed specific IPs
followed by immunoblot assays. As shown in Figure 1, CD9 was
detected in the anti-CD36 IP from wt but not cd36 null cells (Panel
A). Similarly, CD36 was detected in the anti-CD9 IP from wt cells
(Panel B). Isotype matched control antibodies were used as
controls in all studies. To further demonstrate specificity, we
performed an IP with an antibody to an irrelevant macrophage
surface protein, CD31, and found no evidence by western blot of
co-precipitated CD36. Similarly anti-CD36 IPs did not contain
detectable CD31 (not shown).
CD9 and CD36 co-localize on the macrophage cell
surface
Because of potential artifacts introduced by detergent lysis of
membrane proteins, we also examined CD9 and CD36 association
by immunofluorescence microscopy. The confocal images shown
in Figure 2A demonstrate that both CD9 and CD36 are densely
expressed on the macrophage cell plasma membrane in a ‘‘ring’’
pattern. The merged image shown in the far right panel shows
nearly complete overlap of fluorescence from the two markers. We
then used a Proximity Ligation Cross Linking Assay (OLink, Inc)
with anti-CD9 and anti-CD36 antibodies derived from 2 different
species (rabbit and mouse). In this system, species specific
secondary antibodies conjugated to unique DNA strands that
template hybridization of specific oligonucleotides are then added,
and when in close proximity (,40 nm) the oligonucleotides can be
ligated to form a circular template. The template can then be
amplified and detected using specific complementary oligonucle-
otide probes tagged with fluorescent probes. Single-molecule
protein-protein interaction events are visualized as distinct
fluorescent spots. Figure 2B, panel a shows distinct spot formation
in WT macrophages using this system with anti-CD9 and anti-
CD36 antibodies. To show specificity we demonstrated that no
spots were formed on cd36 null cells with these antibodies
(Figure 2B, panel b) and that no spots were formed when CD31
or CD40 antibodies were used instead of CD9 on WT cells (panels
c and d). To confirm these results, we also used FITC-labeled anti-
CD36 and biotin-labeled anti-CD9 mouse antibodies or biotin-
labeled anti-CD31 rat IgG as primary antibody sets to repeat the
experiment with secondary anti-FITC and anti-biotin antibodies
for detection. The results were similar (not show). These studies
thus show that CD9 and CD36 are in close proximity to each
other (within 40 nM) on the surface of macrophages.
CD9 participates in CD36-mediated macrophage
functions
To investigate the role of CD9 in the biological functions of
CD36, we first studied oxLDL uptake and foam cell formation
using macrophages obtained from cd9 null mice. For these studies
we used a form of oxidized LDL highly specific for CD36 (termed
NO2LDL) that is generated by incubating human LDL with a
myeloperoxidase/nitrite-based oxidizing system. In a short term
experiment using DiI-labeled NO2LDL we found that fluores-
cence uptake at 15–60 minutes was moderately decreased in cd9
deleted macrophage compared to wt macrophages (Figure 3A). To
determine the quantitative impact of this defect on foam cell
formation we incubated wt and cd9 null macrophages with
NO2LDL for 16 hours. Cells were then stained with Oil Red O
and neutral lipid content was assessed by extracting and
quantifying the dye. Figure 3B shows, as expected, that cd36 null
macrophages accumulated little or no lipid, and that the cd9 null
cells accumulated significantly less that wt, but more than the cd36
null. To confirm these results we also assayed total cholesterol
content in the cell lysates (Figure 3C) and showed a 26% decrease
in cd9 null cells compared to wt cells (p=0.02). No differences
among the genotypes were seen in cells incubated with native
LDL. Flow cytometry assays with monoclonal anti-CD9 IgG
showed that the level of surface expression of CD9 was not
changed in cd36 null macrophages (data not shown; p=0.8).
Previous studies from our lab revealed that phosphorylation of
the MAP kinase JNK is a proximal event in CD36 signaling in
macrophages and that JNK inhibition blocks CD36-mediated
uptake of oxidized LDL [17]. We thus tested the hypothesis that
CD9 contributes to CD36 signaling by examining the extent and
kinetics of JNK phosphorylation in cd9 null macrophages after
exposure to NO2LDL. Figure 4 shows western blots with an
antibody specific to phospho-JNK. Both JNK1 and JNK2 were
phosphorylated in wt cells, with an approximate 6 fold increase
seen at 15 minutes. Phosphorylation was still increased by more
than 4 fold at 30 minutes. Interestingly, in the cd9 null cells
NO2LDL incubation induced a similar degree of JNK activation
as in wt at 15 minutes, but by 30 minutes there was significantly
less activation in the cd9 cells, suggesting that CD9 might regulate
this pathway. As expected, minimal JNK phosphorylation was
seen in cd36 null cells.
CD9 Influences CD36 Function in Macrophages
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The tetraspanin CD9 (Tspan 29) is expressed on platelets,
macrophages, vascular endothelial and smooth muscle cells,
neuronal cells, fibroblasts, oocytes and some epithelial cells [33].
It is among the best studied of the tetraspanins and has been
shown to regulate several biologically important cellular functions,
including sperm-egg fusion [36], and adhesion, proliferation, and
migration of nucleated cells. It is densely expressed on platelets
where it appears to play a role in modulating and stabilizing
aggregration. The mechanisms by which CD9 and other
tetraspanins regulate cell functions remain incompletely under-
stood, but the prevailing model is that they associate with one
another and with other membrane proteins to form a ‘‘tetraspanin
web’’ that clusters specific membrane components and intracel-
lular signaling molecules into microdomains that facilitate signal
transduction [31]. Interaction of CD9 with specific ß1 and ß3
integrins has been shown to regulate fertilization [37], migration,
adhesion and platelet aggregation. In addition to integrins, CD9
also associates with the Ig superfamily adhesion molecule ICAM,
and with membrane associated growth factors.
Although Maio et al. previously showed that CD9 could be co-
immunoprecipitated with CD36 in human platelet lysates [34], and
Kazerounian et al recently reported the association of CD36 with
the tetraspanins CD9 and CD151 in endothelial cells [35], a
functional role for the interactionwasnotshown,norwasitshown if
CD9 and CD36 co-localize in intact cells. In this report we show
withseveraldifferent experimental approachesthat CD9and CD36
co-associate on macrophage cell membranes. Immunoprecipation
with monoclonal antibodies to either protein precipitated the other,
Figure 1. Co-immunoprecipitation of CD9 and CD36 from macrophage lysates. Peritoneal macrophages from wt or cd36 null mice were
lysed in 1% CHAPS and lysates containing 750 mg protein were incubated with agarose beads conjugated to murine monoclonal anti-mouse CD36
IgA (A) or anti-CD9 IgG and control rat IgG (B) at 4uC overnight. Immunoprecipitated (IP) proteins were then analyzed by immunoblot (IB) using anti-
CD9 or anti-CD36 antibodies.
doi:10.1371/journal.pone.0029092.g001
Figure 2. Co-localization of CD9 and CD36 on macrophage plasma membrane. (A) Confocal Microscopy. Mouse peritoneal macrophages
were seeded on glass coverslips, fixed in 4% formaldehyde, and then incubated with FITC-conjugated anti-CD36 IgA (left panel; green fluorescence)
or unlabeled rabbit anti-CD9 IgG followed by Alexa-594 conjugated goat anti-rabbit IgG (middle panel; red fluorescence). Cells were also incubated
with DAPI (Blue) to detect nuclei. Confocal images were obtained at (636); insets show (66636). Right panel shows merged images. (B) Proximity
Ligation Cross-linking Assay. Macrophages from wild type (a) or cd36 null (b) mice were incubated with rat anti-CD36 monoclonal IgG and rabbit anti-
CD9 antibody and then species specific DNA-conjugated secondary antibodies. Specific oligonucleotides were then added, ligated and amplified
using complementary fluorescent probes. Fluorescent dots represent cross-linked antibodies. In panels c and d, wild type macrophages were
incubated with rabbit anti-CD36 IgG, but with anti-CD31 (c) or anti-CD40 (d) as negative controls.
doi:10.1371/journal.pone.0029092.g002
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ligation cross-linking assay’’ demonstrated that the two proteins are
closely associated (within 40 nM) with one another on the surface of
the cells. Most protein interactions involving tetraspanins are not
due to direct binding between specific peptide domains, with the
exception that the second extracellular domain of CD9 has been
shown to bind directly to integrins [33]. Whether CD9 and CD36
bind to each other directly remains to be determined.
Our studies also suggest that the CD36 signaling pathways
triggered by oxLDL which lead to cholesterol accumulation and
foam cell formation may be facilitated in part by its association in
tetraspanin webs. Genetic deletion of CD9 did not abolish foam
cell formation, but oxLDL uptake was modestly decreased as were
total lipid and cholesterol accumulation. Interestingly, in the
absence of CD9, CD36-mediated activation of JNK was altered,
with more rapid loss of phosphorylation and thus presumably
more rapid termination of the signal. JNK activation is a critical
step in foam cell formation and atherogenesis, as inhibition or
deletion of JNK has been shown by our group to block CD36-
mediated oxLDL uptake [17] and by others to inhibit atheroscle-
rosis in an apoe null mouse model [38]. We also showed that JNK
inhibition in platelets blocked CD36-mediated pro-thrombotic
responses [21]. Thus modulation of the dynamics of CD36-
mediated JNK activation by CD9 could account for the differences
seen in oxLDL uptake and foam cell formation in cd9 null
macrophages. The mechanisms responsible for the alteration in
JNK phosphorylation kinetics in the absence of CD9 remains to be
determined, but possibilities include changes in recruitment of src
family and/or MAP kinases to the CD36 signaling complex or
alteration of phosphatase function. Our studies showing less
cellular lipid accumulation in the absence of CD9 are also
consistent with reports that tetraspanins can traffic between the
plasma membrane and intracellular vesicular compartments and
therefore potentially regulate internalization pathways [39].
In summary, we showed that CD9 and CD36 co-associate on the
macrophage surface, suggesting that CD36 may be part of the
tetraspanin web. Loss of this association by genetic deletion of CD9
led to a modest but statistically significant decrement in CD36-
mediated signaling in response to oxLDL and a concomitant
modest decrease in lipid accumulation and foam cell formation.
Materials and Methods
Animals, antibodies and other reagents
cd36 null mice [40], and cd9 null mice [41] were described
previously. All mouse studies were approved by the Cleveland
Figure 3. CD9 null macrophages have impaired uptake of oxidized LDL. (A) Peritoneal macrophages from cd9 null (top row) or wild type
(bottom row) mice were incubated with DiI-labeled NO2LDL (10 mg/ml) for timed periods from 0–60 minutes at 37uC. Fluorescent images show that
wild type cells took up more DiI (red) than cd9 nulls. Blue fluorescence represents DAPI-stained cell nuclei. White arrows indicate the macrophages
with high number of lipid droplet formation. (B) Peritoneal macrophages from cd9 null, cd36 null, or wild type mice were incubated with NO2LDL
(50 mg/ml) for 16 hours at 37uC and then fixed and stained with oil red O for 30 minutes. After washing, the dye was extracted from the cells by
methanol and detected by absorbance at 520 nM. Each group represents the mean of 3 individual samples. (C) Macrophages were treated with
oxLDL as in B, or with native LDL, and then lysed. Total cellular cholesterol and protein were then quantified. Each group represents the mean of 3
individual samples.
doi:10.1371/journal.pone.0029092.g003
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ID is ARC08938). Peritoneal macrophages were obtained by
lavage 4 d after injection with thioglycollate and adherent cells
were maintained in culture. Cell culture reagents were purchased
from Invitrogen, CA, USA. Antibodies to phosphorylated forms of
JNK1/2 and to total JNK1/2 were from Cell Signaling, Beverly,
MA. Unlabeled or biotin-conjuncted mouse monoclonal anti-CD9
antibody was from BD Biosciences, CA, USA. Rabbit anti-CD9
monoclonal antibody was purchased from Epitomics, CA, USA.
Mouse anti-mouse CD36 IgA was prepared as previously
described [28]. Rat anti-mouse CD36 IgG was a kind gift from
Prof. Laura Helming (Munich, Germany) [42]. Rabbit anti-CD36
antibody was from Novus biologicals, CO, USA. Anti-CD31 and
anti-CD40 for Proximity Ligation Cross-linking Assay were from
BD Biosciences, CA, USA. LDL was isolated from human plasma
as previously described [17] and oxidized with a myeloperoxidase
based system as previously described [3]. In some experiments
LDL was exposed to all elements of the system except the oxidant
to create control non-oxidized LDL. All chemicals were obtained
from Sigma (St. Louis, MO, USA) unless otherwise indicated.
Co-Immunoprecipitation (Co-IP)
Mouse monoclonal anti-mouse CD36 IgA was coupled to NHS-
activated agarose beads (GE life sciences, NJ, USA) according to
manufacturer’s instruction. Peritoneal macrophages were treated
with Dithiobis-succinimidylpropionate and then lysed in 1%
CHAPS in buffer made up of 50 mM Tris-HCl (pH 7.5),
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, and a
broad spectrum protease inhibitor cocktail (Roche Applied
Science, IN, USA). Lysates were centrifuged at 12000 g for
10 min and the supernatants containing 750 mg protein were
incubated with antibody beads rotating overnight at 4uC. After
extensive washing, beads were boiled in SDS-PAGE loading buffer
and the bound material run on SDS-PAGE for further analysis.
Mass Spectrometry
Lanes from SDS-PAGE gels prepared as above from wt and
cd36 null macrophages were cut horizontally into 10 sections. The
gel pieces were then reduced with DTT and alkylated with
iodoacetamide before digestion with trypsin overnight. Peptides
were then extracted from the gel slices and the extracts evaporated
to ,30 ml for LC-MS analysis using a Finnegan LCQ ion trap
mass spectrometer system. The HPLC column was a self-packed
8c m 675 mM internal diameter Phenomenex Jupiter C18 reverse-
phase capillary chromatography column. Peptides were eluted
from the column by an acetonitrile/0.05 M acetic acid gradient
and introduced into the mass spectrometer on-line. The micro-
electrospray ion source was operated at 2.5 kV. Data were
analyzed using all CID spectra collected to search NCBI databases
with the search program Mascot.
Figure 4. OxLDL induced JNK phosphorylation is reduced in cd9 null macrophages. (A) Peritoneal macrophages from wild type, cd9 null
and cd36 null mice were stimulated by oxidized LDL (50 mg/ml) for timed points from 0–30 minutes. Cells were then lysed and analyzed by western
blot with antibodies to phosphor-JNK (top) or total JNK (bottom). (B) Blots from (A) were scanned and band densities quantified using NIH Image-J
software. The ratios of p-JNK/total JNK are indicated, each group represents the mean of 3 individual samples.
doi:10.1371/journal.pone.0029092.g004
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For co-IP studies proteins from SDS-PAGE gels prepared as
described above were transferred to PVDF membranes (BioRad,
CA, USA) and probed with specific antibodies to CD36 and CD9
using a chemiluminescence based detection system (GE life
sciences). In some studies the IP was done with anti-CD9 beads
instead of anti-CD36. For studies of JNK activation, cells were
treated with oxidized LDL (50 mg/ml) for timed periods and then
washed twice in ice-cold PBS before lysis in 50 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-
40, 0.5% sodium deoxycholate, 2.5 mM sodium pyrophosphate,
1m M b-glycerophosphate, 1 mM Na3VO4, and proteinase
inhibitor cocktail. After centrifuging at 12000 g for 10 minutes,
the cleared supernatants were run on SDS-PAGE, transferred
onto PVDF membranes, and probed with antibodies to phospho-
JNK using a chemiluminescence detection system. Blots were
stripped and re-probed with antibodies to control proteins (b-actin
or JNK) to assess loading. For quantification, blots were scanned
and band densities determined using NIH Image-J software.
Immnofluorescence microscopy
Peritoneal macrophages from wt mice were seeded on coverslips
and cultured in RPMI 1640 medium supplied with 10% FCS.
Attached cells were fixed in 4% formaldehyde and then incubated
with FITC-labeled monoclonal anti-CD36 IgA (Cayman Chem-
ical, Mi, USA) and/or unlabeled anti-CD9 antibody followed by
Alexa-594 labeled Goat anti-rabbit antibody (Invitrogen, CA,
USA). Cells were then counterstained with DAPI to detect nuclei
and analyzed by laser confocal fluorescence microscopy.
Proximity Ligation Cross-linking Assay
Fixed peritoneal macrophages prepared as above were
incubated with rabbit anti-CD9 and rat anti-CD36 monoclonal
antibodies. Coverslips were then washed and incubated with
species specific secondary antibodies (DuolinkH; Olink, Inc)
conjugated to unique DNA strands that serve as templates for
hybridization of specific oligonucleotides. The oligonucleotides
were then added as per the manufacturer’s protocol along with a
ligase to form a circular template. The anchored template was
then amplified and detected using complementary fluorescently
labeled probes. Distinct spots representing single-molecule protein
interaction events were visualized using a laser confocal fluores-
cence microscope.
oxLDL uptake and foam cell formation
Peritoneal macrophages from wt, cd9 null and cd36 null mice
adherent to coverslips were incubated with DiI-labeled NO2LDL
(10 mg/ml) for timed points up to 60 minutes at 37uC. Cells were
then fixed in 4% formaldehyde and internalized fluorescence
examined by confocal microscopy. In other studies cells were
cultured in 12 well plates, incubated with 50 mg/ml unlabeled
NO2LDL for 16 hours, and then fixed with 4% formaldehyde and
stained with Oil Red O to detect neutral lipids. After washing
away non-bound dye, the internalized Oil Red O was extracted in
methanol and quantified by absorbance at 520 nm using a 96 well
plate reader (Spectra Max 190, Molecular Devices). Total cellular
cholesterol content was also assessed in parallel cultures using a
commercial kit (Cayman Chemical, MI, USA).
Statistical analysis
In vitro assays were performed in quadruplicate cultures. All
experiments were done using macrophages from at least three
mice for each group. All numerical results are expressed as mean
6 SEM. Statistical differences were determined by Student’s t test.
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